• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background: Streptococci frequently cause infective endocarditis (IE), yet the prevalence of
IE in patients with bloodstream infections (BSIs) caused by different streptococcal species is …

Background Infective endocarditis is a microbial infection of the endocardial surface of the
heart. Antibiotics are the cornerstone of treatment, but due to the differences in presentation …

Purpose This study aimed at identifying the main antimicrobial resistance of ESKAPE
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter …

Infections with carbapenem-resistant Enterobacteriaceae are emerging as an important
challenge in healthcare settings. Currently, carbapenem-resistant Klebsiella pneumoniae …

The second edition of Practical Cardiovascular Pathology provides an essential text and
colour atlas helping all general pathologists to identify a wide range of cardiovascular …

We aimed to explore factors for optimizing antimicrobial treatment in emergency
departments. A single-day point prevalence survey was conducted on January 18, 2020, in …

Fever of unknown origin (FUO) is a serious challenge for physicians. The aim of the present
study was to consider epidemiology and dynamics of FUO in countries with different …

Background Infective endocarditis (IE) is diagnosed in 7–8% of streptococcal bloodstream
infections (BSIs), yet it is unclear when to perform transthoracic (TTE) and transoesophageal …

Prosthetic valve endocarditis (PVE) remains a serious condition with a high mortality rate.
Precise identification of the PVE-associated pathogen/s and their virulence is essential for …